55 related articles for article (PubMed ID: 38526879)
1. Synergistic effects of ceftazidime/avibactam combined with meropenem in a murine model of infection with KPC-producing Klebsiella pneumoniae.
Zheng M; Li FH; Liu J; Li WJ; Yin RX; Cai DT; Andrey DO; Zheng SL; Gales AC; Zhang WJ; Sun J; Liao XP; Yu Y
J Antimicrob Chemother; 2024 May; 79(5):1069-1080. PubMed ID: 38526879
[TBL] [Abstract][Full Text] [Related]
2. Effect of ceftazidime-avibactam combined with different antimicrobials against carbapenem-resistant
Wu Y; Yu W; Chu X; Zhang J; Jia P; Liu X; Zhu Y; Xu Y; Yang Q
Microbiol Spectr; 2024 Jun; 12(6):e0010724. PubMed ID: 38712934
[TBL] [Abstract][Full Text] [Related]
3. Emergence of ceftazidime-avibactam resistance in bla
Zhou J; Yan G; Tang C; Liu J; Fu P; Ding L; Yang W; Guo Y; Wang C; Lu G; Hu F
Int J Antimicrob Agents; 2024 Jun; 63(6):107163. PubMed ID: 38570018
[TBL] [Abstract][Full Text] [Related]
4. A novel KPC-166 in ceftazidime/avibactam resistant ST307 Klebsiella pneumoniae causing an outbreak in intensive care COVID Unit, Italy.
Piazza A; Mattioni Marchetti V; Bielli A; Biffignandi GB; Piscopiello F; Giudici R; Tartaglione L; Merli M; Vismara C; Migliavacca R
J Microbiol Immunol Infect; 2024 Jun; 57(3):457-469. PubMed ID: 38584042
[TBL] [Abstract][Full Text] [Related]
5. In vitro mimicry of in vivo KPC mutations by ceftazidime-avibactam: phenotypes, mechanisms, genetic structure and kinetics of enzymatic hydrolysis.
Shen S; Tang C; Yang W; Ding L; Han R; Shi Q; Guo Y; Yin D; Hu F
Emerg Microbes Infect; 2024 Dec; 13(1):2356146. PubMed ID: 38743401
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms responsible KPC-135-mediated resistance to ceftazidime-avibactam in ST11-K47 hypervirulent
Shi Q; Shen S; Tang C; Ding L; Guo Y; Yang Y; Wu S; Han R; Yin D; Hu F
Emerg Microbes Infect; 2024 Dec; 13(1):2361007. PubMed ID: 38801099
[TBL] [Abstract][Full Text] [Related]
7. Ceftazidime-Avibactam resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae: A phenotypic and genotypic analysis.
Krithika VM; Ganesan V; Rajendran T
Indian J Med Microbiol; 2024; 49():100603. PubMed ID: 38705276
[TBL] [Abstract][Full Text] [Related]
8. First report of KPC variants conferring ceftazidime-avibactam resistance in Colombia: introducing KPC-197.
De la Cadena E; Mojica MF; Rojas LJ; Castro BE; García-Betancur JC; Marshall SH; Restrepo N; Castro-Caro NP; Fonseca-Carrillo M; Pallares C; Bonomo RA; Villegas MV
Microbiol Spectr; 2024 Jun; 12(6):e0410523. PubMed ID: 38700337
[TBL] [Abstract][Full Text] [Related]
9. Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia.
Shields RK; Nguyen MH; Chen L; Press EG; Potoski BA; Marini RV; Doi Y; Kreiswirth BN; Clancy CJ
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559250
[TBL] [Abstract][Full Text] [Related]
10. Whole genome sequencing analysis of seven unknown resistance mechanisms of carbapenem-resistant Klebsiella pneumoniae strains resistance to ceftazidime-avibactam.
Chen Y; Huang J; Chen H; Xiao H; Shen X; Chen Q; Zhang Z; Huang Y; Wu S; Chen D
J Appl Microbiol; 2024 Jun; 135(6):. PubMed ID: 38849309
[TBL] [Abstract][Full Text] [Related]
11. Genomic characterization of carbapenemase-producing Klebsiella pneumoniae ST307 revealed multiple introductions in Buenos Aires, Argentina.
González-Espinosa F; Di Pilato V; Magariños F; Di Conza J; Rossolini GM; Gutkind G; Radice M; Cejas D
J Glob Antimicrob Resist; 2024 Jun; 37():176-178. PubMed ID: 38583573
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous post-neurosurgical ventriculitis and bacteraemia by two different strains of KPC-producing K. pneumoniae successfully treated with meropenem/vaborbactam and high dose of fosfomycin.
Volpicelli L; Cairoli S; Al Ismail D; Baisi F; Sacco F; Goffredo BM; Venditti M; Oliva A
J Glob Antimicrob Resist; 2024 Jun; 37():86-90. PubMed ID: 38519025
[TBL] [Abstract][Full Text] [Related]
13. Enhancing resistance, but not virulence attributed to the high mortality caused by carbapenem-resistant Klebsiella pneumoniae.
Yang C; Xu Q; Xie M; Tang Y; Hu Q; Heng H; Yang X; Liu X; Chan EW; Yang G; Chen S
Microbiol Res; 2024 Aug; 285():127769. PubMed ID: 38797112
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of ceftazidime/avibactam and plazomicin on carbapenem-resistant Klebsiella pneumoniae and Escherichia coli.
Öztaş S; Er DK; Dündar D; Keçeli SA
Acta Microbiol Immunol Hung; 2024 Jun; ():. PubMed ID: 38837219
[TBL] [Abstract][Full Text] [Related]
15. sRNA expression profile of KPC-2-producing carbapenem-resistant Klebsiella pneumoniae: Functional role of sRNA51.
Bai Y; Xie C; Zhang Y; Zhang Z; Liu J; Cheng G; Li Y; Wang D; Cui B; Liu Y; Qin X
PLoS Pathog; 2024 May; 20(5):e1012187. PubMed ID: 38718038
[TBL] [Abstract][Full Text] [Related]
16. Using host-mimicking conditions and a murine cutaneous abscess model to identify synergistic antibiotic combinations effective against
Lyons N; Wu W; Jin Y; Lamont IL; Pletzer D
Front Cell Infect Microbiol; 2024; 14():1352339. PubMed ID: 38808066
[TBL] [Abstract][Full Text] [Related]
17. The prevalence and mechanisms of heteroresistance to ceftazidime/avibactam in KPC-producing Klebsiella pneumoniae.
Zhang X; Zeng W; Kong J; Huang Z; Shu H; Tang M; Qian C; Xu C; Zhou T; Ye J
J Antimicrob Chemother; 2024 Jun; ():. PubMed ID: 38842536
[TBL] [Abstract][Full Text] [Related]
18. Integrated Transcriptomic and Metabolomic Mapping Reveals the Mechanism of Action of Ceftazidime/Avibactam against Pan-Drug-Resistant
Hussein M; Allobawi R; Zhao J; Yu H; Neville SL; Wilksch J; Wong LJM; Baker M; McDevitt CA; Rao GG; Li J; Velkov T
ACS Infect Dis; 2023 Dec; 9(12):2409-2422. PubMed ID: 37878861
[TBL] [Abstract][Full Text] [Related]
19. In vivo emergence of cefiderocol and ceftazidime/avibactam cross-resistance in KPC-producing Klebsiella pneumoniae following ceftazidime/avibactam -based therapies.
Amadesi S; Amedeo A; Rinaldi M; Palombo M; Giannella M; Gaibani P
Diagn Microbiol Infect Dis; 2024 May; 110(1):116372. PubMed ID: 38875893
[TBL] [Abstract][Full Text] [Related]
20. Pharmacoepidemiology of Ceftazidime-Avibactam Use: A Retrospective Cohort Analysis of 210 US Hospitals.
Strich JR; Ricotta E; Warner S; Lai YL; Demirkale CY; Hohmann SF; Rhee C; Klompas M; Palmore T; Powers JH; Dekker JP; Adjemian J; Matsouaka R; Woods CW; Danner RL; Kadri SS
Clin Infect Dis; 2021 Feb; 72(4):611-621. PubMed ID: 32107536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
